UTRS logo

Minerva Surgical, Inc. Stock Price

OTCPK:UTRS Community·US$8.9k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

UTRS Share Price Performance

US$0.001
0.00 (99,900.00%)
US$0.001
0.00 (99,900.00%)
Price US$0.001

UTRS Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Minerva Surgical, Inc. Key Details

US$51.7m

Revenue

US$23.7m

Cost of Revenue

US$28.0m

Gross Profit

US$61.5m

Other Expenses

-US$33.4m

Earnings

Last Reported Earnings
Sep 30, 2023
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About UTRS

Founded
2008
Employees
n/a
CEO
Darin Hammers
WebsiteView website
minervasurgical.com

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Recent UTRS News & Updates

Recent updates

No updates